Phase 2 trial of remibrutinib shows promising results for managing Sjögren’s syndrome
A recent Phase 2 clinical trial, published in the Annals of Rheumatic Diseases, has revealed encouraging results for remibrutinib, an experimental drug, in treating moderate-to-severe …